Skip to main content
Top
Published in: Journal of Radiation Oncology 3-4/2020

01-12-2020 | Lung Cancer | Letter to the Editor

Brain metastases from small cell lung cancer: survival after whole brain radiotherapy versus stereotactic radiosurgery of recursive partitioning analysis class I–II patients

Authors: Federico L. Ampil, Troy Richards

Published in: Journal of Radiation Oncology | Issue 3-4/2020

Login to get access

Excerpt

To the Editors-in-Chief, …
Literature
1.
go back to reference Kocher M, Maarouf M, Bendel M, Voges J, Muller RP, Sturm V (2004) Linac radiosurgery versus whole brain radiotherapy for brain metastases: a survival comparison based on the RTOG recursive partitioning analysis. Strahlentherapie Onkol 180:263–267CrossRef Kocher M, Maarouf M, Bendel M, Voges J, Muller RP, Sturm V (2004) Linac radiosurgery versus whole brain radiotherapy for brain metastases: a survival comparison based on the RTOG recursive partitioning analysis. Strahlentherapie Onkol 180:263–267CrossRef
2.
go back to reference Videtic GMM, Adelstein DJ, Mekhail TM, Rice TW, Stevens GHJ, Lee SY, Suh JH (2007) Validation of the RTOG recursive partitioning analysis (RPA) classification for small-cell lung cancer-only brain metastases. Int J Radiat Oncol Biol Phys 67:240–243CrossRef Videtic GMM, Adelstein DJ, Mekhail TM, Rice TW, Stevens GHJ, Lee SY, Suh JH (2007) Validation of the RTOG recursive partitioning analysis (RPA) classification for small-cell lung cancer-only brain metastases. Int J Radiat Oncol Biol Phys 67:240–243CrossRef
3.
go back to reference Glare P, Sinclair C, Downing M, Stone P, Maltoni M, Vigano A (2008) Predicting survival in patients with advanced disease. Eur J Cancer 44:1146–1150CrossRef Glare P, Sinclair C, Downing M, Stone P, Maltoni M, Vigano A (2008) Predicting survival in patients with advanced disease. Eur J Cancer 44:1146–1150CrossRef
4.
go back to reference Cordeiro D, Xu Z, Shepard M, Sheehan D, Li C, Sheehan J (2019) Gamma knife radiosurgery for brain metastases from small-cell lung cancer: institutional experience over more than a decade and review of the literature. J Radiosurg SBRT 6:35–43PubMedPubMedCentral Cordeiro D, Xu Z, Shepard M, Sheehan D, Li C, Sheehan J (2019) Gamma knife radiosurgery for brain metastases from small-cell lung cancer: institutional experience over more than a decade and review of the literature. J Radiosurg SBRT 6:35–43PubMedPubMedCentral
5.
go back to reference Robin TP, Jones BL, Amini A, Koshy M, Gaspar LE, Liu AK, Nath SK, Kavanagh BD, Camidge DR, Rusthoven CG (2018) Radiosurgery alone is associated with favorable outcome for brain metastases from small-cell lung cancer. Lung Cancer 120:88–90CrossRef Robin TP, Jones BL, Amini A, Koshy M, Gaspar LE, Liu AK, Nath SK, Kavanagh BD, Camidge DR, Rusthoven CG (2018) Radiosurgery alone is associated with favorable outcome for brain metastases from small-cell lung cancer. Lung Cancer 120:88–90CrossRef
6.
go back to reference Bernhardt D, Hommertgen A, Schmitt D, El Shafie R, Paul A, Konig L, Mair-Walther J, Krisam J, Klose C, Welzel T, Horner-Rieber J, Kappes J, Thomas M, Heubel CP, Steins M, Kieser M, Debus J, Rieken S (2018) Whole brain radiation therapy alone versus radiosurgery for patients with 1-10 brain metastases from small cell lung cancer (ENCEPHALON Trial): study protocol for a randomized controlled trial. Trials 19:388CrossRef Bernhardt D, Hommertgen A, Schmitt D, El Shafie R, Paul A, Konig L, Mair-Walther J, Krisam J, Klose C, Welzel T, Horner-Rieber J, Kappes J, Thomas M, Heubel CP, Steins M, Kieser M, Debus J, Rieken S (2018) Whole brain radiation therapy alone versus radiosurgery for patients with 1-10 brain metastases from small cell lung cancer (ENCEPHALON Trial): study protocol for a randomized controlled trial. Trials 19:388CrossRef
Metadata
Title
Brain metastases from small cell lung cancer: survival after whole brain radiotherapy versus stereotactic radiosurgery of recursive partitioning analysis class I–II patients
Authors
Federico L. Ampil
Troy Richards
Publication date
01-12-2020
Publisher
Springer Berlin Heidelberg
Published in
Journal of Radiation Oncology / Issue 3-4/2020
Print ISSN: 1948-7894
Electronic ISSN: 1948-7908
DOI
https://doi.org/10.1007/s13566-020-00428-w

Other articles of this Issue 3-4/2020

Journal of Radiation Oncology 3-4/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine